Serum oxidized low-density lipoprotein levels are related to cardiometabolic risk and decreased after a weight loss treatment in obese children and adolescents

Carregando...
Imagem de Miniatura
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
MORELL-AZANZA, Lydia
GARCIA-CALZON, Sonia
MARTIN-CALVO, Nerea
CHUECA, Maria
MARTINEZ, Jose Alfredo
AZCONA-SANJULIAN, Maria Cristina
MARTI, Amelia
Citação
PEDIATRIC DIABETES, v.18, n.5, p.392-398, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background and aimsThe oxidation of low-density lipoprotein (LDL) cholesterol particles is an early atherogeninic event. Obese pediatric populations have higher levels of oxidized LDL (oxLDL) than normal weight children. The aim of this study was to evaluate the effect of a weight loss program on the biochemical profile and oxLDL levels in Spanish obese children and adolescents. MethodsForty obese children (mean age 11 years, 51% boys) followed a 10-week weight loss program. They were dichotomized at the median of body mass index-standard deviation score (BMI-SDS) change, as high (HR) and low responders (LR) after the intervention. The intervention included a moderate energy-restricted diet, nutritional education, and family involvement. Anthropometric and biochemical measurements were performed at the beginning and during the follow up. A cardiometabolic risk score (CMS) was calculated considering metabolic risk factors. ResultsHigher baseline oxLDL levels were associated with a higher CMS in obese children (P<.001). After the intervention, oxLDL significantly decreased in the HR group. Moreover, a positive correlation between changes in oxLDL and BMI-SDS (r=0.385, P=.015) was found after the weight loss program. Interestingly, multiple-adjusted regression models showed an association between changes in total cholesterol [B: 0.127, 95% confidence interval (CI): 0.06 to 0.20] and LDL-cholesterol (B: 0.173, 95% CI: 0.08 to 0.26) with changes in oxLDL. ConclusionsHigher baseline oxLDL levels were associated with a higher CMS in obese children. After the weight loss program, a decrease in oxLDL levels was found in HR subjects and the oxLDL levels were associated with BMI-SDS and cholesterol levels.
Palavras-chave
BMI-SDS, dietary intervention, LDL-cholesterol, pediatrics
Referências
  1. Albuali Waleed H, 2014, World J Clin Pediatr, V3, P6, DOI 10.5409/wjcp.v3.i1.6
  2. Chae JS, 2013, NUTR RES, V33, P195, DOI 10.1016/j.nutres.2013.01.005
  3. Codoner-Franch P, 2011, ATHEROSCLEROSIS, V215, P475, DOI 10.1016/j.atherosclerosis.2010.12.035
  4. Cole TJ, 2000, BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
  5. de la Iglesia R, 2013, INT J MOL SCI, V14, P6903, DOI 10.3390/ijms14046903
  6. Galcheva SV, 2011, EUR J ENDOCRINOL, V164, P553, DOI 10.1530/EJE-10-1124
  7. Galle J, 2006, ATHEROSCLEROSIS, V185, P219, DOI 10.1016/j.atherosclerois.2005.10.005
  8. Ibero-Baraibar I, 2014, NUTR METAB CARDIOVAS, V24, P416, DOI 10.1016/j.numecd.2013.09.017
  9. Kelishadi R, 2008, CLIN CHEM, V54, P147, DOI 10.1373/clinchem.2007.089953
  10. Kelly AS, 2010, PEDIATR DIABETES, V11, P552, DOI 10.1111/j.1399-5448.2009.00640.x
  11. Linna MS, 2007, INT J OBESITY, V31, P245, DOI 10.1038/sj.ijo.0803413
  12. Loffredo L, 2012, J PEDIATR-US, V161, P1004, DOI 10.1016/j.jpeds.2012.05.042
  13. Maiolino G, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/714653
  14. Marin MT, 2015, J DIABETES COMPLICAT, V29, P679, DOI 10.1016/j.jdiacomp.2015.03.015
  15. Matusik P, 2015, BIOMED RES INT, DOI 10.1155/2015/315747
  16. McCrindle BW, 2015, CAN J CARDIOL, V31, DOI 10.1016/j.cjca.2014.08.017
  17. Nascimento H, 2015, DIABETOL METAB SYNDR, V23, P4
  18. Okur I, 2013, J PEDIATR ENDOCR MET, V26, P657, DOI 10.1515/jpem-2012-0374
  19. Rendo-Urteaga T, 2014, EUR J PEDIATR, V173, P609, DOI 10.1007/s00431-013-2229-7
  20. Rendo-Urteaga T, 2015, BRIT J NUTR, V113, P331, DOI 10.1017/S0007114514003584
  21. Rendo-Urteaga T, 2013, METABOLISM, V62, P1429, DOI 10.1016/j.metabol.2013.05.011
  22. Sanchez-Cruz JJ, 2013, REV ESP CARDIOL, V66, P371, DOI [10.1016/j.rec.2012.10.012, 10.1016/j.recesp.2012.10.016]
  23. Sanders RH, 2015, EUR J PEDIATR, V174, P715, DOI 10.1007/s00431-015-2551-3
  24. Schindhelm RK, 2009, CLIN CHEM, V55, P1462, DOI 10.1373/clinchem.2009.126029
  25. Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5
  26. Shin MJ, 2006, INT J OBESITY, V30, P1529, DOI 10.1038/sj.ijo.0803304
  27. Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821
  28. Sobradillo A, FUNDACION CURVAS TAB
  29. Sociedad Espanola de Nutricion Comunitaria, GUIA AL SAL
  30. Stringer DM, 2009, PEDIATR DIABETES, V10, P269, DOI 10.1111/j.1399-5448.2008.00473.x
  31. Tjonna AE, 2009, CLIN SCI, V116, P317, DOI 10.1042/CS20080249
  32. Tumova E, 2013, J OBES, V2013, P1
  33. Yngve A, 2008, EUR J PUBLIC HEALTH, V18, P126, DOI 10.1093/eurpub/ckm099